Fogo AB - Search Results

1

PPAR-gamma agonist protects podocytes from injury.

Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB. Kanjanabuch T, et al. Among authors: fogo ab. Kidney Int. 2007 Jun;71(12):1232-9. doi: 10.1038/sj.ki.5002248. Epub 2007 Apr 25. Kidney Int. 2007. PMID: 17457378 Free article.

2

Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity.

Fogo A, Hellings SE, Inagami T, Kon V. Fogo A, et al. Kidney Int. 1992 Sep;42(3):770-4. doi: 10.1038/ki.1992.346. Kidney Int. 1992. PMID: 1405355 Free article.

3

Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion.

Yoshioka T, Fogo A, Beckman JK. Yoshioka T, et al. Kidney Int. 1992 Apr;41(4):1008-15. doi: 10.1038/ki.1992.153. Kidney Int. 1992. PMID: 1513081 Free article.

4

Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure.

Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A. Kakinuma Y, et al. Kidney Int. 1992 Jul;42(1):46-55. doi: 10.1038/ki.1992.259. Kidney Int. 1992. PMID: 1635354 Free article.

5

Complement activation retards resolution of acute ischemic renal failure in the rat.

Schulman G, Fogo A, Gung A, Badr K, Hakim R. Schulman G, et al. Kidney Int. 1991 Dec;40(6):1069-74. doi: 10.1038/ki.1991.316. Kidney Int. 1991. PMID: 1762308 Free article.

6

Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure.

Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, Sakai T, Ichikawa I. Motojima M, et al. Among authors: fogo ab. Kidney Int. 1991 Sep;40(3):461-9. doi: 10.1038/ki.1991.233. Kidney Int. 1991. PMID: 1787646 Free article.

7

Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions.

Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I. Ikoma M, et al. Kidney Int. 1991 Aug;40(2):195-202. doi: 10.1038/ki.1991.200. Kidney Int. 1991. PMID: 1942767 Free article.

8

Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries.

Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I. Kawamura T, et al. Kidney Int. 1991 Aug;40(2):291-301. doi: 10.1038/ki.1991.213. Kidney Int. 1991. PMID: 1942778 Free article.

9

Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys.

Fogo A, Yoshida Y, Yared A, Ichikawa I. Fogo A, et al. Kidney Int. 1990 Dec;38(6):1068-74. doi: 10.1038/ki.1990.314. Kidney Int. 1990. PMID: 2074650 Free article.

10

Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis.

Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC Jr, Ichikawa I. Fogo A, et al. Kidney Int. 1990 Jul;38(1):115-23. doi: 10.1038/ki.1990.175. Kidney Int. 1990. PMID: 2385079 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

579 results

Search Page

Filters